197 related articles for article (PubMed ID: 30758834)
1. The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm.
Mohan V; Cooper ME; Matthews DR; Khunti K
Diabetes Ther; 2019 Mar; 10(Suppl 1):1-13. PubMed ID: 30758834
[TBL] [Abstract][Full Text] [Related]
2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
4. Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives.
Khunti K; Hassanein M; Lee MK; Mohan V; Amod A
Diabetes Ther; 2020 Aug; 11(Suppl 2):33-48. PubMed ID: 32440835
[TBL] [Abstract][Full Text] [Related]
5. Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review.
Sahin I; Bakiner O; Demir T; Sari R; Atmaca A
Diabetes Ther; 2024 Jun; ():. PubMed ID: 38935188
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetes.
Saulsberry WJ; Coleman CI; Mearns ES; Zaccaro E; Doleh Y; Sobieraj DM
Int J Clin Pract; 2015 Nov; 69(11):1221-35. PubMed ID: 26215321
[TBL] [Abstract][Full Text] [Related]
7. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and cost-effectiveness of metformin in different patient populations: A narrative review of real-world evidence.
Solini A; Tricò D
Diabetes Obes Metab; 2024 Jun; ():. PubMed ID: 38939954
[TBL] [Abstract][Full Text] [Related]
9. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
10. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.
Chow CK; Ramasundarahettige C; Hu W; AlHabib KF; Avezum A; Cheng X; Chifamba J; Dagenais G; Dans A; Egbujie BA; Gupta R; Iqbal R; Ismail N; Keskinler MV; Khatib R; Kruger L; Kumar R; Lanas F; Lear S; Lopez-Jaramillo P; McKee M; Mohammadifard N; Mohan V; Mony P; Orlandini A; Rosengren A; Vijayakumar K; Wei L; Yeates K; Yusoff K; Yusuf R; Yusufali A; Zatonska K; Zhou Y; Islam S; Corsi D; Rangarajan S; Teo K; Gerstein HC; Yusuf S;
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):798-808. PubMed ID: 30170949
[TBL] [Abstract][Full Text] [Related]
11. The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR.
Khunti K; Almalki M; Chan JCN; Amod A
Diabetes Ther; 2023 Oct; 14(10):1609-1625. PubMed ID: 37603144
[TBL] [Abstract][Full Text] [Related]
12. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management.
van Baar MJB; van Ruiten CC; Muskiet MHA; van Bloemendaal L; IJzerman RG; van Raalte DH
Diabetes Care; 2018 Aug; 41(8):1543-1556. PubMed ID: 30030256
[TBL] [Abstract][Full Text] [Related]
13. Oral Glucose-lowering Drugs and Cardiovascular Outcomes: From the Negative RECORD and ACCORD to Neutral TECOS and Promising EMPA-REG.
Tsioufis C; Andrikou E; Thomopoulos C; Papanas N; Tousoulis D
Curr Vasc Pharmacol; 2017; 15(5):457-468. PubMed ID: 27928947
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes.
Kwon CS; Seoane-Vazquez E; Rodriguez-Monguio R
BMC Health Serv Res; 2018 Feb; 18(1):78. PubMed ID: 29391064
[TBL] [Abstract][Full Text] [Related]
15. Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas.
Al-Saleh Y; Sabico S; Al-Furqani A; Jayyousi A; Alromaihi D; Ba-Essa E; Alawadi F; Alkaabi J; Hassanein M; Al-Sifri S; Saleh S; Alessa T; Al-Daghri NM
Diabetes Ther; 2021 Aug; 12(8):2115-2132. PubMed ID: 33983614
[TBL] [Abstract][Full Text] [Related]
16. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic drugs and stroke risk. Current evidence.
Castilla-Guerra L; Fernandez-Moreno MDC; Leon-Jimenez D; Carmona-Nimo E
Eur J Intern Med; 2018 Feb; 48():1-5. PubMed ID: 28939005
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone, rosiglitazone, and rosiglitazone + metformin: new drugs. Glitazone + oral antidiabetic combination: inadequately evaluated.
Prescrire Int; 2005 Aug; 14(78):133-9. PubMed ID: 16106595
[TBL] [Abstract][Full Text] [Related]
19. Glucocrinology of Modern Sulfonylureas: Clinical Evidence and Practice-Based Opinion from an International Expert Group.
Kalra S; Das AK; Baruah MP; Unnikrishnan AG; Dasgupta A; Shah P; Sahay R; Shukla R; Das S; Tiwaskar M; Vijayakumar G; Chawla M; Eliana F; Suastika K; Orabi A; Rahim AAA; Uloko A; Bahendeka S; Abdela AA; Mohammed F; Pathan F; Rahman MH; Afsana F; Selim S; Moosa M; Murad M; Shreshtha PK; Shreshtha D; Giri M; Hussain W; Al-Ani A; Ramaiya K; Singh S; Raza SA; Aye TT; Garusinghe C; Muthukuda D; Weerakkody M; Kahandawa S; Bavuma C; Ruder S; Vanny K; Khanolkar M; Czupryniak L
Diabetes Ther; 2019 Oct; 10(5):1577-1593. PubMed ID: 31267358
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
